Skip to main content
SpringerLink
Log in

Concurrent dendritic cell vaccine and strontium-89 radiation therapy in the management of multiple bone metastases

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

In addition to its direct cytotoxic effects, radiation therapy renders tumor cells more susceptible to T cell-mediated cytotoxicity by modulating cell surface molecules involved in antigen presentation. The purpose of the present study was to determine the benefit of combined 89Sr radiation and dendritic cell (DC) vaccine therapy in bone metastasis patients.

Methods

Patients were treated with intravenous 89Sr at a dose of 40 μCi/kg of body weight on the first day after the peripheral blood mononuclear cell collection. Seven days later, patients received DCs once a week for 6 weeks. The first three vaccines were administered by intravenous infusion, and the last three vaccines were administered by 24-point intradermal injection. Clinical response was evaluated by the number of bone metastatic foci demonstrated on bone scintigraphy; cell-mediated cytotoxicity response was evaluated by delayed-type hypersensitivity (DTH) reaction. All treatment-related toxicities including vaccine-induced fever and 89Sr-associated hematological toxicity were carefully monitored.

Results

Twenty-six patients with histologically diagnosed with primary cancers and multiple bone metastases demonstrated on bone scintigraphy were studied. The overall survival rate was 58.3 %. The total positive DTH rate was 50 %. The efficiency rate for pain relief was 60 % (6/10), for quantity of life was 80 %, and for clinic responses was 90 %. Out of 10 cases, the Grade 1 or 2 of hematological depression in 4, erythema in 1, and fever in 7 were observed.

Conclusions

The study has important implications for that combined 89Sr radiation, and DC vaccine therapy can benefit cancer patients with bone metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Petrut B, Trinkaus M, Simmons C et al (2008) A primer of bone metastases management in breast cancer patients. Curr Oncol 15:S50–S57. doi:10.3747/co.2008.176

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Sartor AO (2011) Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space. J Hematol Oncol 4:18

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Gridley DS, Williams JR, Slater JM (2005) Low-dose/low-dose-rate radiation: a feasible strategy to improve cancer radiotherapy? Cancer Ther 3:105–130

    Google Scholar 

  4. Reddy EK, Robinson RG, Mansfield CM (1986) Strontium 89 for palliation of bone metastases. J Natl Med Assoc 78:27–32

    PubMed Central  CAS  PubMed  Google Scholar 

  5. Lewington VJ (1993) Targeted radionuclide therapy for bone metastases. Eur J Nucl Med 20:66–74. doi:10.1007/BF02261248

    Article  CAS  PubMed  Google Scholar 

  6. Kraeber-Bodéré F, Campion L, Rousseau C et al (2000) Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement. Eur J Nucl Med 27:1487–1493. doi:10.1007/s002590000315

    Article  PubMed  Google Scholar 

  7. Buchali K, Correns HJ, Schuerer M et al (1988) Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. Eur J Nucl Med 14:349–351

    CAS  PubMed  Google Scholar 

  8. Pons F, Herranz R, Garcia A et al (1997) Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer. Eur J Nucl Med 24:1210–1214. doi:10.1007/s002590050143

    Article  CAS  PubMed  Google Scholar 

  9. Kasalický J, Krajská V (1988) The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases. Eur J Nucl Med 25:1362–1367

    Google Scholar 

  10. Soliman H (2010) Developing an effective breast cancer vaccine. Cancer Control 17:183–190

    PubMed  Google Scholar 

  11. Nguyen-Pham TN, Lee YK, Lee HJ et al (2012) Cellular immunotherapy using dendritic cells against multiple myeloma. Korean J Hematol 47:17–27. doi:10.5045/kjh.2012.47.1.17

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Thomas-Kaskel AK, Zeiser R, Jochim R et al (2006) Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival. Int J Cancer 119:2428–2434. doi:10.1002/ijc.22097

    Article  CAS  PubMed  Google Scholar 

  13. Kiessling A, Füssel S, Wehner R et al (2008) Advances in specific immunotherapy for prostate cancer. Eur Urol 53:694–708. doi:10.1016/j.eururo.2007.11.043

    Article  CAS  PubMed  Google Scholar 

  14. Kim CH, Woo SJ, Park JS et al (2007) Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma. Immunology 122:615–622. doi:10.1111/j.1365-2567.2007.02680.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Nguyen-Pham TN, Lee YK, Kim HJ et al (2012) Immunotherapy using dendritic cells against multiple myeloma: how to improve? Clin Dev Immunol 2012:397648. doi:10.1155/2012/397648

    Article  PubMed Central  PubMed  Google Scholar 

  16. Sharp HJ, Wansley EK, Garnett CT et al (2007) Synergistic antitumor activity of immune strategies combined with radiation. Front Biosci 12:4900–4910. doi:10.2741/2436

    Article  CAS  PubMed  Google Scholar 

  17. Tseng CW, Trimble C, Zeng Q et al (2008) Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts. Cancer Immunol Immunother 58:737–748. doi:10.1007/s00262-008-0596-0

    Article  PubMed Central  PubMed  Google Scholar 

  18. Finkelstein SE, Timmerman R, McBride WH et al (2011) The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol 2011:439752. doi:10.1155/2011/439752

    Article  PubMed Central  PubMed  Google Scholar 

  19. Persson BRR, Koch CB, Grafström G, et al. (2011) “Abscopal” effect of radiation therapy combined with immune-therapy using IFN-γ gene transfected syngeneic tumor cells, in rats with bilateral implanted N29 tumors. ISRN Immunol 230130. doi:10.5402/2011/230130

  20. Reissfelder C, Timke C, Schmitz-Winnenthal H et al (2011) A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer. BMC Cancer 11:419. doi:10.1186/1471-2407-11-419

    Article  PubMed Central  PubMed  Google Scholar 

  21. Liu Y, Zhang W, Zhang B et al (2013) DC vaccine therapy combined concurrently with oral capecitabine in metastatic colorectal cancer patients. Hepatogastroenterology 60:23–27. doi:10.5754/hge12522

    CAS  PubMed  Google Scholar 

  22. Luo J, Sun Y, Wu G et al (1996) Development and assessment of quality of life questionnaire for Chinese cancer patients. J Pract Oncol 11:252–254

    Google Scholar 

  23. Hovey E, Marx G, Kneebone A et al (2009) An Australian clinical perspective: management of hormone refractory (androgen-independent) prostate cancer. Asia Pac J Oncol Hematol 1:77–88

    Google Scholar 

  24. Ma Y, Kepp O, Ghiringhelli F et al (2010) Chemotherapy and radiotherapy: cryptic anticancer vaccines. Semin Immunol 22:113–124. doi:10.1016/j.smim.2010.03.001

    Article  PubMed  Google Scholar 

  25. Lin CC, Wang TE, Liu CY et al (2008) Potentiation of the immunotherapeutic effect of autologous dendritic cells by pretreating hepatocellular carcinoma with low-dose radiation. Clin Invest Med 31:E150–E159

    CAS  PubMed  Google Scholar 

  26. Chakraborty M, Wansley EK, Carrasquillo JA et al (2008) The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing. Clin Cancer Res 14:4241–4249. doi:10.1158/1078-0432.CCR-08-0335

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Teitz-Tennenbaum S, Li Q, Davis MA et al (2009) Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer. J Immunother 32:602–612. doi:10.1097/CJI.0b013e3181a95165

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Ridolfi L, Petrini M, Fiammenghi L et al (2010) Unexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysis. Clin Dev Immunol 2010:504979. doi:10.1155/2010/504979

    Article  PubMed Central  PubMed  Google Scholar 

  29. Rotow J, Gameiro SR, Madan RA et al (2010) Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci 3:116–122. doi:10.1111/j.1752-8062.2010.00186.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Molecule Imaging and Nuclear Medicine in Diagnosis and Treatment, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    J. Liu & K. Chang

  2. Department of Oncology, Tianjin Union Medicine Centre, Tianjin, China

    J. Li, Y. Fan, X. Yang, W. Zhu, X. Wu & Yan Pang

  3. Shanghai Claison Biotechnology Co. Ltd, Shanghai, China

    J. Li & X. Yang

  4. Institute of Oncology, Tianjin Union Medicine Centre, Tianjin, China

    X. Wu

Authors
  1. J. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. X. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. X. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yan Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan Pang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Li, J., Fan, Y. et al. Concurrent dendritic cell vaccine and strontium-89 radiation therapy in the management of multiple bone metastases. Ir J Med Sci 184, 457–461 (2015). https://doi.org/10.1007/s11845-014-1145-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-014-1145-9

Keywords

Search

Navigation